NanoString Technologies, Inc. (NSTG)

8.76 -0.16 (-1.79%) As of 10:20AM EDT. Market open.

NanoString Technologies, Inc.

530 Fairview Avenue North
Seattle, WA 98109
United States
206 378 6266
https://www.nanostring.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 766

Key executives

Name	Title	Pay	Exercised	Year born
Mr. R. Bradley Gray	CEO, Pres & Director	1.12M	3.47M	1977
Mr. K. Thomas Bailey M.B.A.	Chief Financial Officer	629.08k	1.36M	1969
Dr. Joseph M. Beechem	Chief Scientific Officer and Sr. VP of R&D	630.82k	7.52M	1958
Mr. J. Chad Brown	Sr. Advisor	599.59k	912.93k	1958
Mr. Mark A. Winham	Sr. VP of Operations	N/A	N/A	N/A
Mr. Douglas S. Farrell	VP of Investor Relations & Corp. Communications	N/A	N/A	N/A
Ms. Kathryn Surace-Smith	Sr. VP of HR & Legal Affairs and Corp. Sec.	N/A	N/A	1959
Mr. David W. Ghesquiere	Sr. VP of Corp. & Bus. Devel.	N/A	N/A	1967
Elizabeth Schneider Ph.D.	Sr. Global Marketing Mang.	N/A	N/A	N/A
Dr. Mary Tedd Allen	Sr. VP of Strategic Initiatives	N/A	N/A	1963

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

Corporate governance

NanoString Technologies, Inc.’s ISS governance QualityScore as of 1 February 2023 is 8. The pillar scores are Audit: 7; Board: 3; Shareholder rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.